Clinical trial
A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant…
NCT00195429 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00195429 |
|---|---|
| Title | A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant Recipients |
| Official title | A Randomized, Open-label and Multicenter Trial Comparing Withdrawal of Steroids or Tacrolimus From Sirolimus-based Immunosuppressive Regimen in de Novo Renal Allograft Recipients |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Failure, Graft vs Host Disease |
| Intervention type | Drug |
| Interventions | Tacrolimus, Sirolimus, prednisone |
| Enrollment | 47 |
| Start date | Aug 1, 2005 |
| Completion | Oct 1, 2007 |
| First posted | Sep 19, 2005 |
| Last update posted | Dec 11, 2023 |
| Countries | Brazil |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: